Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

1-25 of 134 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

Predictive and prognostic factors in patients with Anaplastic Lymphoma Kinase: rearranged early-stage lung adenocarcinoma.
Gallina FT, Cecere FL, Tajè R, Bertolaccini L, Casiraghi M, Spaggiari L, Cannone G, Busetto A, Rea F, Martucci N, De Luca G, Mercadante E, Mazzoni F, Bongiolatti S, Voltolini L, Melis E, Sperduti I, Cappuzzo F, Rayes R, [...] Spicer J
Eur J Cardiothorac Surg, ezae406, 12 Nov 2024
Cited by: 0 articles | PMID: 39531280
Add to export list
Simultaneous versus staged approach in transcatheter aortic valve implantation for severe stenosis and endovascular aortic repair for thoracic and abdominal aortic aneurysm.
Gallitto E, Spath P, Faggioli GL, Saia F, Palmerini T, Piazza M, D'Oria M, Simonte G, Cappiello A, Isernia G, Gelpi G, Rizza A, Piffaretti G, Gargiulo M, Italian Multicenter T/EVAR + TAVI Study’s Group
Eur J Cardiothorac Surg, 66(5):ezae379, 01 Nov 2024
Cited by: 0 articles | PMID: 39441830 | PMCID: PMC11534088
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Erratum to "Brief Report: Canadian Cancer Trials Group IND.227: A Phase II randomized study of pembrolizumab in patients with advanced malignant pleural mesothelioma (NCT02784171). [Journal of Thoracic Oncology Vol. 18 No. 6: 813-819]".
Piccirillo MC, Chu Q, Bradbury P, Tu W, Coschi CH, Grosso F, Florescu M, Mencoboni M, Goffin JR, Pagano M, Ciardiello F, Cecere FL, Vincent M, Ferrara R, Dawe DE, Hao D, Lee CW, Morabito A, Gridelli C, [...] Laurie SA
J Thorac Oncol, 19(11):1578-1579, 24 Aug 2024
Cited by: 0 articles | PMID: 39186030
Add to export list
Osimertinib in Patients With Treatment-Naive EGFR-Mutant Non-small Cell Lung Cancer: Overall Survival, Post-progression Management and Budget Impact Analysis in Real-World.
Pasello G, Lorenzi M, Scattolin D, Del Conte A, Cecere F, Pavan A, Macerelli M, Polo V, Pilotto S, Santarpia M, Cumerlato E, Da Ros V, Targato G, Bortolami A, Bonanno L, Ferro A, Dal Maso A, Frega S, Guarneri V
Oncologist, 29(7):596-608, 01 Jul 2024
Cited by: 0 articles | PMID: 38520745 | PMCID: PMC11224988
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
A novel iPSC-based model of ICF syndrome subtype 2 recapitulates the molecular phenotype of ZBTB24 deficiency.
Lullo V, Cecere F, Batti S, Allegretti S, Morone B, Fioriniello S, Pisapia L, Genesio R, Della Ragione F, Giardino G, Pignata C, Riccio A, Matarazzo MR, Strazzullo M
Front Immunol, 15:1419748, 08 Jul 2024
Cited by: 0 articles | PMID: 39040103 | PMCID: PMC11260623
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Urgent endovascular repair of juxtarenal/pararenal aneurysm by off-the-shelf multibranched endograft.
Gallitto E, Faggioli G, Austermann M, Kölbel T, Tsilimparis N, Dias N, Melissano G, Simonte G, Katsargyris A, Oikonomou K, Mani K, Pedro LM, Cecere F, Haulon S, Gargiulo M, European Off-the-shelf Multibranched thoracoabdominal Endograft for Juxta/pararenal aneurysms (EOMEJ) Study's group
J Vasc Surg, 80(5):1336-1349.e4, 09 Jul 2024
Cited by: 1 article | PMID: 38992807
Add to export list
New insights into oocyte cytoplasmic lattice-associated proteins.
Giaccari C, Cecere F, Argenziano L, Pagano A, Riccio A
Trends Genet, 40(10):880-890, 01 Jul 2024
Cited by: 0 articles | PMID: 38955588
Add to export list Review
A novel iPSC-based model of ICF syndrome subtype 2 recapitulates the molecular phenotype of ZBTB24 deficiency
Lullo V, Cecere F, Batti S, Allegretti S, Morone B, Fioriniello S, Pisapia L, Genesio R, Ragione FD, Giardino G, Pignata C, Riccio A, Matarazzo MR, Strazzullo M
bioRxiv, 21 Apr 2024
Cited by: 0 articles | PPR: PPR840776
Add to export list Preprint
A maternal-effect Padi6 variant causes nuclear and cytoplasmic abnormalities in oocytes, as well as failure of epigenetic reprogramming and zygotic genome activation in embryos.
Giaccari C, Cecere F, Argenziano L, Pagano A, Galvao A, Acampora D, Rossi G, Hay Mele B, Acurzio B, Coonrod S, Cubellis MV, Cerrato F, Andrews S, Cecconi S, Kelsey G, Riccio A
Genes Dev, 38(3-4):131-150, 22 Mar 2024
Cited by: 3 articles | PMID: 38453481 | PMCID: PMC10982689
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed.
Leonetti A, Perrone F, Puntoni M, Maglietta G, Bordi P, Bria E, Vita E, Gelsomino F, De Giglio A, Gelibter A, Siringo M, Mazzoni F, Caliman E, Genova C, Bertolini F, Guaitoli G, Passiglia F, Delcuratolo MD, Montrone M, [...] Tiseo M
Eur J Cancer, 202:114006, 11 Mar 2024
Cited by: 0 articles | PMID: 38489861
Add to export list
Understanding the Variability of 22q11.2 Deletion Syndrome: The Role of Epigenetic Factors.
Cillo F, Coppola E, Habetswallner F, Cecere F, Pignata L, Toriello E, De Rosa A, Grilli L, Ammendola A, Salerno P, Romano R, Cirillo E, Merla G, Riccio A, Pignata C, Giardino G
Genes (Basel), 15(3):321, 29 Feb 2024
Cited by: 0 articles | PMID: 38540380 | PMCID: PMC10969806
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
ICF1-Syndrome-Associated DNMT3B Mutations Prevent De Novo Methylation at a Subset of Imprinted Loci during iPSC Reprogramming.
Verma A, Poondi Krishnan V, Cecere F, D'Angelo E, Lullo V, Strazzullo M, Selig S, Angelini C, Matarazzo MR, Riccio A
Biomolecules, 13(12):1717, 28 Nov 2023
Cited by: 1 article | PMID: 38136588 | PMCID: PMC10741953
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Analysis of predictive factors of unforeseen nodal metastases in resected clinical stage I NSCLC.
Gallina FT, Marinelli D, Tajè R, Forcella D, Alessandrini G, Cecere FL, Fusco F, Visca P, Sperduti I, Ambrogi V, Cappuzzo F, Melis E, Facciolo F
Front Oncol, 13:1229939, 07 Nov 2023
Cited by: 1 article | PMID: 38023117 | PMCID: PMC10661928
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial.
Chu Q, Perrone F, Greillier L, Tu W, Piccirillo MC, Grosso F, Lo Russo G, Florescu M, Mencoboni M, Morabito A, Cecere FL, Ceresoli GL, Dawe DE, Zucali PA, Pagano M, Goffin JR, Sanchez ML, Gridelli C, Zalcman G, [...] Seymour L
Lancet, 402(10419):2295-2306, 03 Nov 2023
Cited by: 7 articles | PMID: 37931632
Add to export list
The Molecular Tumor Board of the Regina Elena National Cancer Institute: from accrual to treatment in real-world.
Giacomini P, Valenti F, Allegretti M, Pallocca M, De Nicola F, Ciuffreda L, Fanciulli M, Scalera S, Buglioni S, Melucci E, Casini B, Carosi M, Pescarmona E, Giordani E, Sperati F, Jannitti N, Betti M, Maugeri-Saccà M, Cecere FL, [...] Ciliberto G
J Transl Med, 21(1):725, 16 Oct 2023
Cited by: 1 article | PMID: 37845764 | PMCID: PMC10577953
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
A maternal-effectPadi6variant results in abnormal nuclear localization of DNMT1 and failure of epigenetic reprogramming and zygotic genome activation in mouse embryos
Giaccari C, Cecere F, Argenziano L, Galvao A, Acampora D, Rossi G, Mele BH, Cubellis MV, Cerrato F, Andrews S, Cecconi S, Kelsey G, Riccio A
bioRxiv, 10 Oct 2023
Cited by: 0 articles | PPR: PPR739648
Add to export list Preprint
Could the molecular profile aid in predicting occult nodal metastasis in early-stage lung adenocarcinoma?
Gallina FT, Cecere FL, Tajè R, Forcella D, Melis E, Cappuzzo F, Facciolo F
Surg Today, 54(3):288-289, 21 Sep 2023
Cited by: 0 articles | PMID: 37733185
Add to export list
Surgical and survival outcomes with perioperative or neoadjuvant immune-checkpoint inhibitors combined with platinum-based chemotherapy in resectable NSCLC: A systematic review and meta-analysis of randomised clinical trials.
Marinelli D, Gallina FT, Pannunzio S, Di Civita MA, Torchia A, Giusti R, Gelibter AJ, Roberto M, Verrico M, Melis E, Tajè R, Cecere FL, Landi L, Nisticò P, Porciello N, Occhipinti M, Brambilla M, Forde PM, Liu SV, [...] Santini D
Crit Rev Oncol Hematol, 192:104190, 21 Oct 2023
Cited by: 7 articles | PMID: 37871779
Add to export list Review
Co-occurrence of Beckwith-Wiedemann syndrome and pseudohypoparathyroidism type 1B: coincidence or common molecular mechanism?
Pignata L, Cecere F, Acquaviva F, D'Angelo E, Cioffi D, Pellino V, Palumbo O, Palumbo P, Carella M, Sparago A, De Brasi D, Cerrato F, Riccio A
Front Cell Dev Biol, 11:1237629, 10 Aug 2023
Cited by: 2 articles | PMID: 37635873 | PMCID: PMC10448386
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Scalable GMP-compliant gene correction of CD4+ T cells with IDLV template functionally validated in vitro and in vivo.
Asperti C, Canarutto D, Porcellini S, Sanvito F, Cecere F, Vavassori V, Ferrari S, Rovelli E, Albano L, Jacob A, Sergi Sergi L, Montaldo E, Ferrua F, González-Granado LI, Lougaris V, Badolato R, Finocchi A, Villa A, Radrizzani M, Naldini L
Mol Ther Methods Clin Dev, 30:546-557, 23 Aug 2023
Cited by: 3 articles | PMID: 37693944 | PMCID: PMC10482894
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
KRAS G12C mutation and risk of disease recurrence in stage I surgically resected lung adenocarcinoma.
Gallina FT, Marinelli D, Melis E, Forcella D, Taje R, Buglioni S, Visca P, Torchia A, Cecere FL, Botticelli A, Santini D, Ciliberto G, Cappuzzo F, Facciolo F
Lung Cancer, 181:107254, 24 May 2023
Cited by: 2 articles | PMID: 37253296
Add to export list
[Management of the patient with extensive stage microcytoma. The importance of collaboration between oncology and radiotherapy.]
Minuti G, Stefani A, Trodella L, Antonini Cappellini G, Cecere F, Dionisi F, Di Salvatore M, Mariotti S, Mazzarella C, Nelli F, Pisegna S, Ricciardi S, Russano M, Ramella S, Bria E, Cappuzzo F
Recenti Prog Med, 114(7):414-425, 01 Jul 2023
Cited by: 0 articles | PMID: 37392104
Add to export list
Brief Report: Canadian Cancer Trials Group IND.227: A Phase 2 Randomized Study of Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma (NCT02784171).
Piccirillo MC, Chu Q, Bradbury P, Tu W, Coschi CH, Grosso F, Florescu M, Mencoboni M, Goffin JR, Pagano M, Ciardiello F, Cecere FL, Vincent M, Ferrara R, Dawe DE, Hao D, Lee CW, Morabito A, Gridelli C, [...] Laurie SA
J Thorac Oncol, 18(6):813-819, 24 Feb 2023
Cited by: 10 articles | PMID: 36841541
Add to export list
Co-Occurrence of Beckwith-Wiedemann Syndrome and Early-Onset Colorectal Cancer.
Cecere F, Pignata L, Hay Mele B, Saadat A, D'Angelo E, Palumbo O, Palumbo P, Carella M, Scarano G, Rossi GB, Angelini C, Sparago A, Cerrato F, Riccio A
Cancers (Basel), 15(7):1944, 23 Mar 2023
Cited by: 3 articles | PMID: 37046605 | PMCID: PMC10093120
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Pralsetinib in RET fusion-positive non-small-cell lung cancer: A real-world data (RWD) analysis from the Italian expanded access program (EAP).
Passaro A, Russo GL, Passiglia F, D'Arcangelo M, Sbrana A, Russano M, Bonanno L, Giusti R, Metro G, Bertolini F, Grisanti S, Carta A, Cecere F, Montrone M, Massa G, Perrone F, Simionato F, Guaitoli G, Scotti V, [...] de Marinis F
Lung Cancer, 174:118-124, 09 Nov 2022
Cited by: 6 articles | PMID: 36379124
Add to export list

1-25 of 134 results

1 2 3 Next ...

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

Predictive and prognostic factors in patients with Anaplastic Lymphoma Kinase: rearranged early-stage lung adenocarcinoma.

Simultaneous versus staged approach in transcatheter aortic valve implantation for severe stenosis and endovascular aortic repair for thoracic and abdominal aortic aneurysm.

Erratum to "Brief Report: Canadian Cancer Trials Group IND.227: A Phase II randomized study of pembrolizumab in patients with advanced malignant pleural mesothelioma (NCT02784171). [Journal of Thoracic Oncology Vol. 18 No. 6: 813-819]".

Osimertinib in Patients With Treatment-Naive EGFR-Mutant Non-small Cell Lung Cancer: Overall Survival, Post-progression Management and Budget Impact Analysis in Real-World.

A novel iPSC-based model of ICF syndrome subtype 2 recapitulates the molecular phenotype of ZBTB24 deficiency.

Urgent endovascular repair of juxtarenal/pararenal aneurysm by off-the-shelf multibranched endograft.

New insights into oocyte cytoplasmic lattice-associated proteins.

A novel iPSC-based model of ICF syndrome subtype 2 recapitulates the molecular phenotype of ZBTB24 deficiency

A maternal-effect Padi6 variant causes nuclear and cytoplasmic abnormalities in oocytes, as well as failure of epigenetic reprogramming and zygotic genome activation in embryos.

Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed.

Understanding the Variability of 22q11.2 Deletion Syndrome: The Role of Epigenetic Factors.

ICF1-Syndrome-Associated DNMT3B Mutations Prevent De Novo Methylation at a Subset of Imprinted Loci during iPSC Reprogramming.

Analysis of predictive factors of unforeseen nodal metastases in resected clinical stage I NSCLC.

Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial.

The Molecular Tumor Board of the Regina Elena National Cancer Institute: from accrual to treatment in real-world.

A maternal-effectPadi6variant results in abnormal nuclear localization of DNMT1 and failure of epigenetic reprogramming and zygotic genome activation in mouse embryos

Could the molecular profile aid in predicting occult nodal metastasis in early-stage lung adenocarcinoma?

Surgical and survival outcomes with perioperative or neoadjuvant immune-checkpoint inhibitors combined with platinum-based chemotherapy in resectable NSCLC: A systematic review and meta-analysis of randomised clinical trials.

Co-occurrence of Beckwith-Wiedemann syndrome and pseudohypoparathyroidism type 1B: coincidence or common molecular mechanism?

Scalable GMP-compliant gene correction of CD4+ T cells with IDLV template functionally validated in vitro and in vivo.

KRAS G12C mutation and risk of disease recurrence in stage I surgically resected lung adenocarcinoma.

[Management of the patient with extensive stage microcytoma. The importance of collaboration between oncology and radiotherapy.]

Brief Report: Canadian Cancer Trials Group IND.227: A Phase 2 Randomized Study of Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma (NCT02784171).

Co-Occurrence of Beckwith-Wiedemann Syndrome and Early-Onset Colorectal Cancer.

Pralsetinib in RET fusion-positive non-small-cell lung cancer: A real-world data (RWD) analysis from the Italian expanded access program (EAP).

Partnerships & funding